Pharmaceutical and biotechnology company developing a new class of anti-cancer drugs with a novel mechanism of action: inhibition of the mTOR1/2 signalling pathways and induction of autophagy.
National Ranking1650th
in Spain Regional Ranking19067th
in Western Europe Global Ranking77322nd
worldwide Rankings by